Syringe free vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles provides strong and prolonged protection against tuberculosis.

Syringe free vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles provides strong and prolonged protection against tuberculosis.

Bioneedles are small hollow sugar based needles administered with a simple compressed air device. In the present study we investigate how incorporation of a subunit vaccine based on TB vaccine hybrid Ag85B-ESAT-6 adjuvated with CAF01 into Bioneedles affects its immunogenicity as well as its ability...

Full description

Bibliographic Details
Main Authors:	Dennis Christensen, Thomas Lindenstrøm, Gijsbert van de Wijdeven, Peter Andersen, Else Marie Agger
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-11-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21124731/?tool=EBI

Similar Items

Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01.
by: Jes Dietrich, et al.
Published: (2014-01-01)

Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant.
by: Arun T Kamath, et al.
Published: (2008-01-01)

Solid bioneedle-delivered influenza vaccines are highly thermostable and induce both humoral and cellular immune responses.
by: Peter C Soema, et al.
Published: (2014-01-01)

Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements.
by: Else Marie Agger, et al.
Published: (2008-01-01)

A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A*0201 transgenic mice.
by: Gregers Jacob Gram, et al.
Published: (2009-09-01)

CAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferrets.
by: Cyril Jean-Marie Martel, et al.
Published: (2011-01-01)

ESAT-6-Ag85C-polyHistag Antigen Fusion is Potential as Vaccine Candidate for Tuberculosis
by: Ratu Purwanti, et al.
Published: (2023-04-01)

BpOmpW antigen administered with CAF01 adjuvant stimulates comparable T cell responses to Sigma adjuvant system
by: Julen Tomás-Cortázar, et al.
Published: (2024-03-01)

Cloning, expression and purification of Ag85A-ESAT6 antigens of Mycobacterium tuberculosis as a fusion protein
by: M Shakouri, et al.
Published: (2015-01-01)

Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant
by: Dennis Christensen, et al.
Published: (2018-01-01)

Influenza NG-34 T cell conserved epitope adjuvanted with CAF01 as a possible influenza vaccine candidate
by: Marta Sisteré-Oró, et al.
Published: (2020-04-01)

Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant.
by: Karen S Korsholm, et al.
Published: (2013-01-01)

SAFETY AND IMMUNOGENICITY OF COLD-ADAPTED RECOMBINANT INFLUENZA VECTOR EXPRESSING ESAT-6 AND AG85А ANTIGENS OF M. TUBERCULOSIS
by: M. V. Sergeeva, et al.
Published: (2017-12-01)

Comparison of the Immunogenic Properties of Lactiplantibacillus plantarum Carrying the Mycobacterial Ag85B-ESAT-6 Antigen at Various Cellular Localizations
by: Kamilla Wiull, et al.
Published: (2022-06-01)

Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach.
by: Jose Davila, et al.
Published: (2012-01-01)

Correction: Comparison of the Predicted Population Coverage of Tuberculosis Vaccine Candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a Bioinformatics Approach.
by: Jose Davila, et al.
Published: (2012-01-01)

Immunological memory transferred with CD4 T cells specific for tuberculosis antigens Ag85B-TB10.4: persisting antigen enhances protection.
by: Darragh Duffy, et al.
Published: (2009-12-01)

Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6.
by: Ruhwald, M, et al.
Published: (2017)

ACCUMULATION OF RECOMBINANT FUSION PROTEIN – SECRETORY ANALOG OF Ag85B AND ESAT6 MYCOBACTERIUM TUBERCULOSIS PROTEINS – IN TRANSGENIC Lemna minor L. PLANTS
by: A.A.Peterson, et al.
Published: (2015-10-01)

ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.
by: Truc Hoang, et al.
Published: (2013-01-01)

Fusion of Dendritic Cells Activating Rv2299c Protein Enhances the Protective Immunity of Ag85B-ESAT6 Vaccine Candidate against Tuberculosis
by: Yong Woo Back, et al.
Published: (2020-10-01)

Single-dose Ag85B-ESAT-6 loaded–poly(lactic-co-glycolic acid) nanoparticles confer protective immunity against tuberculosis
by: Malik A, et al.
Published: (2019-05-01)

T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties
by: Thomas Lindenstrøm, et al.
Published: (2018-01-01)

Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b
by: Signe Tandrup Schmidt, et al.
Published: (2020-12-01)

Inactivated Lactobacillus plantarum Carrying a Surface-Displayed Ag85B-ESAT-6 Fusion Antigen as a Booster Vaccine Against Mycobacterium tuberculosis Infection
by: Katarzyna Kuczkowska, et al.
Published: (2019-07-01)

Immune responses following neonatal vaccination with conserved F4 fragment of VtaA proteins from virulent Glaesserella parasuis adjuvanted with CAF®01 or CDA
by: Sergi López-Serrano, et al.
Published: (2023-08-01)

Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract
by: Jeanette Erbo Wern, et al.
Published: (2017-05-01)

Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70
by: Fu-Ying Dai, et al.
Published: (2017-06-01)

CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.
by: Tara Elvang, et al.
Published: (2009-01-01)

CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns
by: Simon D. van Haren, et al.
Published: (2022-08-01)

The role of ESAT-6 in tuberculosis immunopathology
by: Beatriz B. S. Passos, et al.
Published: (2024-04-01)

Enterprise Strategic Analysis and Transformation ESAT
by: Nightingale, Deborah, et al.
Published: (2013)

Enterprise Strategic Analysis for Transformation (ESAT) Overview
by: Lean Advancement Initiative
Published: (2013)

A CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4+ T-cell-dependent strain-transcending protective immunity in rodent models
by: Winter A. Okoth, et al.
Published: (2023-12-01)

Immune Responses to Pandemic H1N1 Influenza Virus Infection in Pigs Vaccinated with a Conserved Hemagglutinin HA1 Peptide Adjuvanted with CAF<sup>®</sup>01 or CDA/αGalCerMPEG
by: Sergi López-Serrano, et al.
Published: (2021-07-01)

A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease
by: Julie Zimmermann, et al.
Published: (2022-02-01)

ESAT-6/CFP10 skin test predicts disease in M. tuberculosis-infected guinea pigs.
by: Karin Weldingh, et al.
Published: (2008-01-01)

Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis.
by: Rolf Billeskov, et al.
Published: (2016-01-01)

IL-12 DNA Displays Efficient Adjuvant Effects Improving Immunogenicity of Ag85A in DNA Prime/MVA Boost Immunizations
by: María Paula Morelli, et al.
Published: (2020-09-01)

Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection
by: Diego A. Espinosa, et al.
Published: (2017-04-01)